Elrig

APRIL 29, 2024

Co-Chair: Millie Fox Co-Chair: Millie Fox Senior Drug Discovery Scientist, AstraZeneca Millie graduated from the University of Sussex with a Biochemistry degree in 2016, which included an industrial placement year at GSK, Stevenage. big pharma or startups/spin off? Where do you enjoy more to work? What pro/cons?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Discovery World

AUGUST 16, 2022

In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. However, these social categories are rather arbitrary and don’t necessarily correspond to the underlying molecular biology of the patient, risking misguided clinical care.

Research 130

Research Clinical Trials Trials Drug Development 130

Codon

FEBRUARY 13, 2024

” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, Doctors commonly encounter at least 13 or 14 bacterial species with drug-resistant strains across a range of infections in different parts of the body. UTIs, diabetic foot ulcers).

Therapies 138

Therapies DNA Virus Clinical Trials 138